estradiol

AssetSmall moleculeAlso BAY86-4891, Estradiol / Drospirenone, BAY98-7078, Estradiol Valerate (EV) / Levomefolate Calcium

Estrogen receptor agonist for hormone replacement

Stage: Approved
Modality: Small molecule
Target: ESR2
Indications: 37
Trials: 176
Developers: 10

Indications

37

Atrophic vaginitis
Approvedaccessdata.fda.gov7 Oct 2026
Hypogonadism
Approvedaccessdata.fda.gov7 Oct 2026
Menopause
Approvedaccessdata.fda.gov7 Oct 2026

34 more

Targets and what it contains5
Owner and partners10
Trials176
Evidence for its targets6
Competitors12
Aging relevance1
Signals15

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 7 Oct 2026 · 60 sources